In this review, the therapeutic strategies targeting NLRP3 inflammasome for the treatment of PD are discussed, including the inhibitors of NLRP3 inflammatory pathways, mitochondria-focused treatments, microRNAs, and other therapeutic molecules. The gene discussed is NLRP3; the disease is Parkinson disease.